Augmentation of Cutaneous Wound Healing by Pharmacologic Mobilization of Endogenous Bone Marrow Stem Cells  Jakub Tolar, John A. McGrath  Journal of Investigative Dermatology  Volume 134, Issue 9, Pages 2312-2314 (September 2014) DOI: 10.1038/jid.2014.209 Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Better and faster skin wound healing achieved by combined action of AMD3100 and tacrolimus. AMD3100 releases bone marrow cells into the peripheral blood, while tacrolimus inhibits calcium-dependent T-cell activation and expansion. This novel approach for boosting innate healing potential, in which blood cells are mobilized and engaged in productive skin repair, is further evidence of systemically administered bone marrow cells migrating to injured skin and contributing to its repair. Journal of Investigative Dermatology 2014 134, 2312-2314DOI: (10.1038/jid.2014.209) Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions

Journal of Investigative Dermatology 2014 134, 2312-2314DOI: (10 Journal of Investigative Dermatology 2014 134, 2312-2314DOI: (10.1038/jid.2014.209) Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions